The Ritedose Corp., a CDMO specializing in sterile Blow Fill Seal (BFS) production, is significantly expanding its production capabilities to meet demand for ophthalmic and respiratory medications.
Enforcement Report - Week of August 9, 2023
Enforcement Report - Week of April 13, 2022
Novo Holdings acquired South Carolina-based sterile injectables manufacturer Ritedose for an undisclosed price.
Ritedose`s Generic Albuterol Sulfate Receives Approval in US
Drug companies turn to blow-fill-seal for vaccines and more